Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 9 studies | 31% ± 17% | |
endothelial cell | 6 studies | 25% ± 7% | |
fibroblast | 5 studies | 25% ± 5% | |
macrophage | 4 studies | 18% ± 1% | |
ciliated cell | 3 studies | 28% ± 1% | |
abnormal cell | 3 studies | 25% ± 3% | |
GABAergic neuron | 3 studies | 30% ± 10% | |
glutamatergic neuron | 3 studies | 40% ± 12% | |
dendritic cell | 3 studies | 20% ± 2% | |
goblet cell | 3 studies | 20% ± 4% | |
intestinal crypt stem cell | 3 studies | 22% ± 3% | |
basal cell | 3 studies | 28% ± 7% | |
astrocyte | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2533.01 | 2642 / 2642 | 100% | 13.42 | 705 / 705 |
esophagus | 100% | 1586.93 | 1445 / 1445 | 100% | 6.18 | 183 / 183 |
prostate | 100% | 1706.21 | 245 / 245 | 100% | 9.04 | 502 / 502 |
uterus | 100% | 1795.39 | 170 / 170 | 100% | 9.62 | 459 / 459 |
thymus | 100% | 2163.06 | 653 / 653 | 100% | 10.84 | 604 / 605 |
breast | 100% | 1723.47 | 459 / 459 | 100% | 10.92 | 1116 / 1118 |
ovary | 100% | 1669.16 | 180 / 180 | 100% | 8.03 | 429 / 430 |
kidney | 100% | 1666.40 | 89 / 89 | 100% | 10.19 | 898 / 901 |
lung | 100% | 1593.77 | 578 / 578 | 99% | 8.64 | 1149 / 1155 |
bladder | 100% | 1711.76 | 21 / 21 | 99% | 7.35 | 501 / 504 |
pancreas | 99% | 1015.36 | 326 / 328 | 100% | 7.19 | 178 / 178 |
intestine | 100% | 1983.46 | 966 / 966 | 99% | 7.38 | 523 / 527 |
stomach | 100% | 1257.56 | 359 / 359 | 99% | 6.47 | 283 / 286 |
skin | 100% | 1673.86 | 1808 / 1809 | 99% | 8.74 | 467 / 472 |
liver | 100% | 845.35 | 225 / 226 | 99% | 8.27 | 402 / 406 |
adrenal gland | 100% | 2277.42 | 258 / 258 | 97% | 8.97 | 223 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 8.79 | 29 / 29 |
muscle | 100% | 2169.10 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1336.87 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.25 | 1 / 1 |
adipose | 100% | 1519.26 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1455.26 | 1333 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 7.47 | 44 / 45 |
heart | 98% | 1611.36 | 841 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 7.28 | 78 / 80 |
peripheral blood | 63% | 701.46 | 584 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016020 | Cellular component | membrane |
GO_0003723 | Molecular function | RNA binding |
GO_0043273 | Molecular function | CTPase activity |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0005524 | Molecular function | ATP binding |
GO_0003924 | Molecular function | GTPase activity |
GO_0017111 | Molecular function | ribonucleoside triphosphate phosphatase activity |
Gene name | NTPCR |
Protein name | Cancer-related nucleoside-triphosphatase (NTPase) (EC 3.6.1.15) (Nucleoside triphosphate phosphohydrolase) Chromosome 1 open reading frame 57, isoform CRA_a (Nucleoside-triphosphatase, cancer-related) |
Synonyms | C1orf57 hCG_15829 |
Description | FUNCTION: Has nucleotide phosphatase activity towards ATP, GTP, CTP, TTP and UTP. Hydrolyzes nucleoside diphosphates with lower efficiency. . |
Accessions | ENST00000366628.10 Q5TDF0 ENST00000366627.4 Q9BSD7 |